In our patient cohorts, we detected CTNNB1 mutations in tissue (25%) and urine (24%) samples at frequencies consistent with previous estimates of CTNNB1 mutation frequency in HCC [26,27,28,29,30]. The gene discussed is CTNNB1; the disease is hepatocellular carcinoma.